These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 565933)

  • 1. Further analysis of the resistance of the diabetic rat to d-amphetamine.
    Marshall JF
    Pharmacol Biochem Behav; 1978 Mar; 8(3):281-6. PubMed ID: 565933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of alloxan-diabetic rats to the behavioral activation induced by d-amphetamine: partial restoration with a high fat/protein diet.
    Marshall JF
    Physiol Behav; 1978 Mar; 20(3):319-22. PubMed ID: 571124
    [No Abstract]   [Full Text] [Related]  

  • 3. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats.
    Marshall JF; Friedman MI; Heffner TG
    Brain Res; 1976 Jul; 111(2):428-32. PubMed ID: 949615
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol.
    Rowland N; Joyce JN; Bellush LL
    Behav Neurosci; 1985 Oct; 99(5):831-41. PubMed ID: 3916385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished reaction to a novel stimulus during amphetamine withdrawal in rats.
    Schreiber H; Bell R; Conely L; Kufner M; Palet J; Wright L
    Pharmacol Biochem Behav; 1976 Dec; 5(6):687-90. PubMed ID: 1035805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats.
    Thornhill JA; Hirst M; Gowdey CW
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1170-8. PubMed ID: 562704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration.
    Rebec GV; Segal DS
    Psychopharmacology (Berl); 1979 Mar; 62(1):101-2. PubMed ID: 108743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol.
    Quattrone A; Bendotti C; Recchia M; Samanin R
    Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats.
    Fessler RG; Sturgeon RD; London SF; Meltzer HY
    Psychopharmacology (Berl); 1982; 78(4):373-6. PubMed ID: 6818601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the locomotor response to d-amphetamine by olfactory bulb damage in rats.
    Gaddy JR; Neill DB
    Pharmacol Biochem Behav; 1976 Aug; 5(2):189-94. PubMed ID: 1033566
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.
    Segal DS; Mandell AJ
    Pharmacol Biochem Behav; 1974; 2(2):249-55. PubMed ID: 4857295
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of the behavioral effects of amphetamine in rats by clonidine.
    Mueller K; Nyhan WL
    Eur J Pharmacol; 1982 Sep; 83(3-4):339-42. PubMed ID: 6293845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine isomers: influences on locomotor and stereotyped behavior of cats.
    North RB; Harik SI; Snyder SH
    Pharmacol Biochem Behav; 1974; 2(1):115-8. PubMed ID: 4857222
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.